Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Ion Torrent is one of the major next generation sequencing (NGS) technologies and it is frequently used in medical research and diagnosis. The built-in software for the Ion Torrent sequencing machines delivers the sequencing results in the BAM format. In addition to the usual SAM/BAM fields, the Ion Torrent BAM file includes technology-specific flow signal data. The flow signals occupy a big portion of the BAM file (about 75% for the human genome). Compressing SAM/BAM into CRAM format significantly reduces the space needed to store the NGS results. However, the tools for generating the CRAM formats are not designed to handle the flow signals. This missing feature has motivated us to develop a new program to improve the compression of the Ion Torrent files for long term archiving.
Results: In this paper, we present IonCRAM, the first reference-based compression tool to compress Ion Torrent BAM files for long term archiving. For the BAM files, IonCRAM could achieve a space saving of about 43%. This space saving is superior to what achieved with the CRAM format by about 8-9%.
Conclusions: Reducing the space consumption of NGS data reduces the cost of storage and data transfer. Therefore, developing efficient compression software for clinical NGS data goes beyond the computational interest; as it ultimately contributes to the overall cost reduction of the clinical test. The space saving achieved by our tool is a practical step in this direction. The tool is open source and available at Code Ocean, github, and http://ioncram.saudigenomeproject.com .
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487613 | PMC |
| http://dx.doi.org/10.1186/s12859-020-03726-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical validation of liquid biopsy-RECIST (LB-RECIST) in metastatic colorectal cancer (mCRC) patients: findings from the PLATFORM-B study.
ESMO Open
September 2025
Hospital del Mar Research Institute Barcelona, Medical Oncology Department, Hospital del Mar, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain. Electronic address:
Background: Circulating tumor DNA (ctDNA) variations predict tumor response to systemic treatment (so-called molecular response) earlier than radiological assessment. However, a standardized categorization of molecular response is an unmet clinical need. Liquid biopsy-RECIST (LB-RECIST), based on aggregate variant allele frequency (aggVAF; sum of all detected variant allele frequencies in a sample) variations, has been proposed to stratify molecular response.
View Article and Find Full Text PDFGenetic characterization of Lynch syndrome germline variants in a LATAM cohort using a customized NGS gene panel.
Front Oncol
August 2025
Unidad Académica de Genética, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
Introduction: Lynch Syndrome accounts for 1-7% of all colorectal cancers and is caused by germline mutations in DNA mismatch repair (MMR) genes. Timely molecular diagnosis is crucial for effective genetic counseling and management. Among understudied Latin American populations, Uruguay's genetic admixture provides an opportunity to identify novel Lynch Syndrome related variants.
View Article and Find Full Text PDFA multiplex targeted NGS panel for identifying pathogens in canine neurological and reproductive diseases.
Front Cell Infect Microbiol
August 2025
Willie M. Reed Laboratory, Indiana Animal Disease Diagnostic Laboratory, Purdue University, West Lafayette, IN, United States.
Introduction: Multiple pathogens can infect the canine reproductive and central nervous systems, including organisms that are zoonotic, such as , pathogenic spp., , , and . In this study, we developed a targeted next-generation sequencing (tNGS) panel to identify common infectious agents related to neurologic and reproductive disease in canines while incorporating less common zoonotic agents into a single test.
View Article and Find Full Text PDFGenomic profiling of cefotaxime-resistant from Norway and Sweden reveals extensive expansion of virulent multidrug-resistant international clones.
Front Microbiol
July 2025
Research Group for Host-Microbe Interactions, Department of Medical Biology, UiT - the Arctic University of Norway, Tromsø, Norway.
Cefotaxime-resistant (CRHI) are a global concern, but little is known about their molecular epidemiology. The goal of this study was to perform genomic profiling of 191 CRHI from Norway ( = 183) or Sweden ( = 8) (2006-2018) and assess clonal spread using core genome multilocus sequence typing (cgMLST)-based Life Identification Number (LIN) codes based on whole genome sequencing (Ion Torrent). Cefotaxime resistance was confirmed with broth microdilution minimal inhibitory concentration (MIC), interpreted with the European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints.
View Article and Find Full Text PDFComparison of Comprehensive Genomic Profiling Testing "Ion Torrent Genexus Sequencer" With FoundationOne.
Anticancer Res
August 2025
Department of Clinical Laboratory Medicine, Kurume University Hospital, Kurume, Japan;
Background/aim: Comprehensive genomic profiling (CGP) with tissue- and blood-based next-generation sequencing (NGS) is integral to the delivery of personalized medicine for targeted cancer therapy. This study aimed to evaluate the variant concordance for somatic variants using two clinical NGS systems for conducting both tissue- and blood-based analyses: Genexus-OCA v3 (OCA) FoundationOne CDx (F1) for tissues and Genexus OPA (OPA) FoundationOne CDx Liquid (F1L) for blood.
Patients And Methods: The concordance of genomic alterations between the two NGS analyses was compared in six patients with breast, head, and neck cancers using tissue and circulating tumor DNA biopsies.